Fund HoldingsGeneral Catalyst Group Management, LLC

Total Portfolio Value
$183.56M
Total Bought
$5.66M
Total Sold
$0
Net Transaction
+$5.66M
Filing Period:
Securities
SharesValue ($K)
Q4 2025
Q1 2026
Change
Q4 2025
Q1 2026
Weight (%)
Change
ARRIVENT BIOPHARMA INC(AVBP)1,494,7861,494,786030,07534,48518.79%+4,410
EIKON THERAPEUTICS INC0305,233+305,23303,2291.76%+3,229
ETHOS TECHNOLOGIES INC(LIFE)074,179+74,17908290.45%+829
COUPANG INC(CPNG)036,677+36,67706920.38%+692
AMAZON COM INC(AMZN)02,582+2,58205380.29%+538
META PLATFORMS INC(META)0658+65803760.21%+376
FIGMA INC(FIG)14,84514,84505553140.17%-241
MAPLEBEAR INC(CART)710,711710,711031,96826,62314.50%-5,345
SAMSARA INC(IOT)2,000,0002,000,000070,90063,38034.53%-7,520
FRACTYL HEALTH INC4,884,1934,884,193010,7452,2361.22%-8,509
MAZE THERAPEUTICS INC(MAZE)1,035,9101,035,910042,91830,92216.85%-11,996
GITLAB INC(GTLB)921,405921,405034,58019,93910.86%-14,641
Page 1 of 1